Interaction between the LMWH reviparin and aspirin in healthy volunteers

This publication has 22 references indexed in Scilit:

• Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects
  European Journal of Clinical Pharmacology, 1998
• Platelet Activation With Unfractionated Heparin at Therapeutic Concentrations and Comparisons With a Low-Molecular-Weight Heparin and With a Direct Thrombin Inhibitor
  Circulation, 1998
• Biochemical and Pharmacologic Characteristics of Reviparin, a Low-Molecular-Mass Heparin
  Seminars in Thrombosis and Hemostasis, 1997
• Low-Molecular-Weight Heparins and Unstable Angina – Current Perspectives
  Pathophysiology of Haemostasis and Thrombosis, 1997
• Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial)
  Journal of the American College of Cardiology, 1996
• Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group.
  Circulation, 1993
• Heparin and low molecular weight heparin but not hirudin stimulate platelet aggregation in whole blood from acetylsalicylic acid treated healthy volunteers
  Thrombosis Research, 1991
• Acetylsalicylic acid and the balance between prostacyclin and thromboxane A2
  Scandinavian Journal of Clinical and Laboratory Investigation, 1990
• Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary Angioplasty
  New England Journal of Medicine, 1988
• Platelet activation following intravenous injection of a conventional heparin: absence of effect with a low molecular weight heparinoid (Org 10172).
  British Journal of Clinical Pharmacology, 1987